Hypoxia-driven immunosuppression contributes to the pre-metastatic niche

OncoImmunology

Volumn 2, Issue 1, 2013, Pages

  Sceneay, Jaclyn ^a,b   Parker, Belinda S ^a,b   Smyth, Mark J ^a,b   Möller, Andreas ^a,b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Bone marrow derived cells; Breast cancer; Hypoxia; Immunosuppression; MDSC; NK cells; Pre metastatic niche

Indexed keywords

CD11B ANTIGEN; CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN LYSINE 6 OXIDASE;

ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CYTOKINE RELEASE; HYPOXIA; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; METASTASIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; TUMOR VOLUME; UPREGULATION;

EID: 84886944303     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.22355     Document Type: Article

References (10)

1. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9:239-52; PMID:19279573; http://dx.doi.org/10.1038/nrc2618.
2. Klein CA. Cancer. The metastasis cascade. Science 2008; 321:1785-7; PMID:18818347; http://dx.doi. org/10.1126/science.1164853.
3. Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009; 9:285-93; PMID:19308068; http://dx.doi.org/10.1038/nrc2621.
4. Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33:207-14; PMID:22398146; http://dx.doi.org/10.1016/j.tips.2012.01.005.
5. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 2009; 15:35-44; PMID:19111879; http://dx.doi.org/10.1016/j. ccr.2008.11.012.
6. + Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche. Cancer Res 2012; 72:3906-11; PMID:22751463; http://dx.doi.org/10.1158/0008-5472.CAN-11-3873.
7. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438:820-7; PMID:16341007; http://dx.doi.org/10.1038/ nature04186.
8. Chioda M, Peranzoni E, Desantis G, Papalini F, Falisi E, Solito S, et al. Myeloid cell diversification and complexity: an old concept with new turns in oncology. Cancer Metastasis Rev 2011; 30:27-43; PMID:21267772; http://dx.doi.org/10.1007/s10555-011-9268-1.
9. Huang B, Lei Z, Zhao J, Gong W, Liu J, Chen Z, et al. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett 2007; 252:86-92; PMID:17257744; http://dx.doi. org/10.1016/j.canlet.2006.12.012.
10. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175.